Macrobiome Therapeutics
Cairns
About Macrobiome Therapeutics
Macrobiome Therapeutics approach to medication discovery and development: Helminths, or parasitic worms, have adapted to live in humans and cause little disease.
Company Facts
- Operating status: Active
- IPO status: Private
- Employees: 11 – 50
- Last round: Non-Equity Assistance (Jul 2024)
- Website: macrobiometherapeutics.com
- Phone: [email protected]
Industries & Categories
Medical
Canonical: https://fsome.com/organization/macrobiome-therapeutics-1769940 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.